Wordt geladen...
The pressing questions in multiple sclerosis Care in the era of COVID-19
• MS patients should continue their disease modifying therapy during the pandemic. • Newly diagnosed patients should start disease modifying therapy without delay. • The effect on COVID-19 infection and future vaccination should be considered. • Agents that cause prolonged non-selective lymphopenia...
Bewaard in:
| Gepubliceerd in: | J Neurol Sci |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier B.V.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7308765/ https://ncbi.nlm.nih.gov/pubmed/32599294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2020.117005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|